Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:09 PM

Novartis AG

Novartis AG - Click to view image in its original context
Novartis AG
Type: Company
Name: Novartis AG
Nationality: Switzerland
Fact Sheet: Fact Sheet for Novartis AG
First Reported 11/19/2009 - Updated 11/20/2009 - 2 Documents
Ablynx will receive an undisclosed milestone payment from Novartis. The payment has been triggered by successful delivery to Novartis of Nanobody candidates which met specific criteria. This will be the third milestone payment that Ablynx has received ... [PharmaBiz - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 4 Documents (in Health)
WASHINGTON (Reuters) As U.S. health officials struggle to vaccinate tens of millions of Americans against the pandemic of swine flu, some are looking regretfully at one easy way to instantly double or triple the number of doses available -- by using an ... [Yahoo! News - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 3 Documents (in Biology)
World Health Organization - Click to view 360-page
World Health Organization
About 40 people have died after being inoculated against H1N1 pandemic flu, but investigations so far show the fatalities were not caused by the vaccine, the World Health Organization said on Thursday.The U.N. agency reaffirmed that the pandemic vaccine ... [Insurance Journal - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 2 Documents (in Health)
Pfizer Inc - Click to view image in its original context
Pfizer Inc
Dublin - Research and Markets (http://www.researchandmarkets.com/research/3a45c7/cancer-therapies) has announced the addition of the ' ' report to their offering.Cancer therapies are geared towards controlling the growth of cancerous tumors, and preventing ... [Pharmacy Choice - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 2 Documents (in Health)
Swiss health authorities have extended authorisation for the swine flu vaccine Pandemrix, produced by pharmaceuticals group GlaxoSmithKline, to those aged over 60.The Swiss Agency for Therapeutic Products (Swissmedic), based in Bern, said that over 60s ... [Swiss Info - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Alkermes, Inc. (USA)AstraZeneca Plc (UK)Boehringer Ingelheim GmbH (Germany)Bristol-Myers Squibb (USA)Cephalon, Inc. (USA)Dainippon Sumitomo Pharma Co., Ltd. (Japan)Elan Corporation Plc (Ireland)Eli Lilly and Co. (USA)Fabre-Kramer Pharmaceuticals, Inc. ... [News-Medical.Net - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Health)
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
Company: Novartis AG (NVS)Sun Pharmaceutical Industries, headquartered in India, has received the FDA's tentative approval for an abbreviated new drug application for generic Gleevec, imatinib mesylate tablets.The imatinib mesylate tablets, therapeutically ... [Zibb - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Marvelle Sullivan, the head of corporate legal M&A at Novartis AG (NYSE:NVS), spoke at The Deal Economy 2010 conference on Wednesday in New York City. In this video, she explains several challenges confronting companies working on cross-border deals, ... [TheDeal.com - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Health)
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT.Pfizer (NYSE: PFE) is at it again. The pharmaceutical giant continues its push to try and beat generic-drug makers at their own game.According to reports Pfizer's ... [Motley Fool - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
BASEL, Switzerland (Nov. 18) Novartis on Tuesday announced new interim data from ongoing clinical trials demonstrating that a single 7.5-µg dose of the company's influenza A(H1N1) 2009 unadjuvanted vaccine, half of the currently approved U.S. dose, fulfilled ... [Drug Store News - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
SWATCH GROUP (UHR.VX), RICHEMONT (CFR.VX)Watch export data due at 0715 GMTROCHE, NOVARTIS (ROG.VX)(NOVN.VX)* Roche and Novartis's asthma drug Xolair should not be approved for children aged 6 to 11, a U.S. advisory panel decided on Wednesday.* Roche unit ... [Reuters UK - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Health)
(CIDRAP News) – Federal officials, along with representatives from four vaccine companies, appeared before two US House of Representatives committees today to answer questions about why the nation hasn't stretched scarce pandemic vaccine supply with adjuvants ... [Centre For Infectious Disease Research and Policy - 11/19/2009]

Quotes

...president of Novartis Vaccines USA, emphasized that adjuvants had been licensed for use in Europe for a decade and tested in some 200,000 people. "Adjuvanted vaccines produce higher immune response than unadjuvanted vaccines particularly in the elderly and young children" Dr. Narasimhan said during the Congressional hearing
...by the Alabama Supreme Court's ruling today,' said Ludwig Hantson, PhD, head of Pharma North America, CEO, Novartis Pharmaceuticals Corporation. "NPC is committed to high ethical standards in the pricing, marketing and sale of all of our products."

More Content

All (2697) | News (2446) | Reports (0) | Blogs (199) | Audio/Video (8) | Fact Sheets (31)
sort by: Date | Relevance
National Domestic Extremism Team (NDET) Issues ... [Corporate Watch - 2 hours ago]
News in Brief - Resisting [Corporate Watch - 2 hours ago]
Dairy lameness roundtable [Progressive Dairy - 4 hours ago]
100,000 doses of A/H1N1 vaccines delivered to M... [Xinhua News Agency - 5 hours ago]
Potential Peak In US Swine Flu Cases [Red Orbit - 7 hours ago]
Innovation Goes Downtown [BusinessWeek - 12 hours ago]
Vaccines are back with a vengeance [Tennessean - 13 hours ago]
Novartis: US interim data show lower doses of a... [Bionity.com - 16 hours ago]
Norway finds H1N1 mutation in victims [CHINAdaily - 17 hours ago]
Jury Sides With Novartis in Generic Famvir Pate... [FDA News - 17 hours ago]
Big Pharma Mergers: Good News Or Bad? [Yahoo! Canada - 20 hours ago]
OvertheCounter Awards 2009 Winners Announced [Farm Business - 21 hours ago]
Mutation seen in some H1N1 deaths [MSNBC - 23 hours ago]
Five million given swine flu jab in EU (AAP) [Yahoo! News Australia - 23 hours ago]
Five million given swine flu jab in EU (AAP) [West Australian - 23 hours ago]
Five million Europeans vaccinated against swine... [Khaleej Times - 11/20/2009]
110M Gemini Sale Is Prague’s Largest [GlobeSt.com - 11/20/2009]
UPDATE 1-Norway says found H1N1 mutation in flu... [FinanzNachrichten.de - 11/20/2009]
Deal Economy 2010: Eydenberg on PE IPOs [TheDeal.com - 11/20/2009]
H1N1 mutation found in some flu fatalities [MSNBC - 11/20/2009]
Norway says found H1N1 mutation in flu fataliti... [West Australian - 11/20/2009]
Now Is the Time to Buy Risk [Motley Fool - 11/20/2009]
Norway says found H1N1 mutation in flu fatalities [Interactive Investor International - 11/20/2009]
NPC compliance made simple with Innovitâs ... [Ferret.com.au - 11/20/2009]
An Undervalued Biotech [Motley Fool UK - 11/20/2009]
Research and Markets: Strategies for Building E... [Forbes.com - 11/20/2009]
FDA actions in brief, November 2009 (FluMist, C... [Modern Medicine - 11/20/2009]
Indian billionaires bounce back: Forbes [Borneo Post Online - 11/20/2009]
Mitsubishi Chemical, Rayon to reunite [Borneo Post Online - 11/20/2009]
Red helps Novartis launch breast cancer reporti... [Brand Republic - 11/20/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Moody’s on Pharma: Outlook Is Negative, But it ... [WSJ.com: Health Blog - 11/20/2009]
Moody’s still thinks the credit ratings of the world’s big drug companies are likely to get worse in the coming months. But Moody’s does find a few good things to ...
Did U.S. make mistake in skipping vaccine addit... [Economy-Finance - 11/20/2009]
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - As U.S. health officials struggle to vaccinate tens of millions of Americans against the pandemic ...
Novartis' Sullivan on cross-border dealmaking [Dealscape - 11/18/2009]
Novartis' Marvelle Sullivan speaks about the challenges of cross-border dealmaking at The Deal Economy 2010 conference. ...
Novartis' Sullivan on cross-border dealmaking [The Deal.com - 11/18/2009]
Novartis' Marvelle Sullivan speaks about the challenges of cross-border dealmaking at The Deal Economy 2010 conference. ...
The Deal Economy 2010: Outlook for global deals [Dealscape - 11/18/2009]
The world is becoming a smaller place when it comes to dealmaking, notes a panel including a corporate dealmaker at Novartis and an attorney from Linklaters. ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
A Jewish Mother in Your Cell Phone [Slate Magazine - 11/10/2009]
How nagging text messages can make you healthie... [Slate Magazine - 11/10/2009]
Dalian 2009 - IdeasLab with INSEAD: Ilian Mihov [World Economic Forum - YouTube - 10/07/2009]
Novartis flu jab [Reuters Video: Business - 10/02/2009]
U.S. clears H1N1 vaccine [Reuters Video: Top News - 09/15/2009]
1 2

  •  
  •  
  •